Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian S Gerstenberger

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Bioorganic & Medicinal Chemistry Letters|August 16, 2012
Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infectionsMark J Mitton-Fry, Joel T Arcari, Matthew F Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cellsDalia Barsyte-Lovejoy, Fengling Li, Menno J Oudhoff, et al.
Nature Communications|March 10, 2026
Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitisJennifer L Duffen, Kimberly K Crouse, Lin Ji, et al.
Journal of Medicinal Chemistry|September 22, 2025
Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 SelectivityMark E Schnute, Huixian Wu, John I Trujillo, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Bioorganic & Medicinal Chemistry Letters|August 16, 2012
Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infectionsMark J Mitton-Fry, Joel T Arcari, Matthew F Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cellsDalia Barsyte-Lovejoy, Fengling Li, Menno J Oudhoff, et al.
Nature Communications|March 10, 2026
Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitisJennifer L Duffen, Kimberly K Crouse, Lin Ji, et al.
Journal of Medicinal Chemistry|September 22, 2025
Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 SelectivityMark E Schnute, Huixian Wu, John I Trujillo, et al.
Pageof 3